#ExSRRF, a new pipeline that allows to reach 25 nm resolution using widefield #microscopy
(useful for #cellbio, #ER_literature, clinics & more)
Tks for the invitation, @PuellesVictor, happy that @cellcommlab we could help you w this neat work
@NatureNano nature.com/articles/s41565-0…
Super happy to present our new super-resolution pipeline that reaches 25nm in FFPE tissues using conventional widefield microscopes! Many thanks to our friends and collaborators!
nature.com/articles/s41565-0…
@PuellesVictor @Tobias_B_Huber @HCKH_Hamburg
@NatureNano
dkylies retweeted
Great work from our Hamburg friends @PuellesVictor @Tobias_B_Huber 🔥🔥👇👇👇
Amazing work from @PuellesVictor on nanoscale imaging on paraffin-embedded tissues!
dkylies retweeted
Amazing work from @PuellesVictor on nanoscale imaging on paraffin-embedded tissues!
New content online: Expansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens dlvr.it/SmGZbC
dkylies retweeted
New content online: Imaging pathology goes nanoscale with a low-cost strategy dlvr.it/SmGZbn
dkylies retweeted
New content online: Expansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens dlvr.it/SmGZbC
dkylies retweeted
Das @BMBF_Bund verlängert die Förderung des STOP-FSGS-Konsortiums unter Leitung des #UKEHamburg. Das Konsortium arbeitet u.a. an der Entwicklung neuer Diagnose- und Therapieansätze zur Behandlung der Nierenerkrankung #FSGS. @Tobias_B_Huber gesundheitsforschung-bmbf.de…
dkylies retweeted
Hamburg news I: Topping out ceremony for our new research campus with Ulf Panzer from our department being the spokesperson of the Hamburg Center for Translational Immunology. @UKEHamburg @HCKH_Hamburg
Weiterer Meilenstein im #Zukunftsplan2050 des #UKEHamburg mit #Richtfest Campus Forschung II & Hamburg Center for Translational Immunology: Optimale Voraussetzungen für translationale Immunitäts-, Infektions- und Entzündungsforschung. bit.ly/3WUgYlg @fegebanks @hh_bwfgb
dkylies retweeted
What a great occasion to get this started! #KidneyWk
hckh.org - Hamburg Center for Kidney Health: From basic biology to disease mechanisms and patient care.
#Tobias_B_Huber
dkylies retweeted
Pretty astounding super high resolution wide field imaging of slit diaphragm & foot processes using ExSSRF & expansion microscopy, resolution of 25 nM, presented by Dominik Kylies, great work! @Tobias_B_Huber @PuellesVictor #KidneyWk
dkylies retweeted
Subcellular spatial proteomics of FFPE tissues🔥!
nature.com/articles/s41587-0…
dkylies retweeted
Forschende des #UKEHamburg haben neue Generkrankung identifiziert. International durchgeführte Arbeit zeigt: Gen Prolyl 3-Hydroxylase 2 (P3H2) stabilisiert Nierenfilter und Mutationen führen zu Nierenschädigung. Ergebnisse in @jclinicalinvest: doi.org/10.1172/JCI147253
dkylies retweeted
Hyperkalemia leads to discontinuation of RAASi.
This unfortunately increase the risk of death.@ISNkidneycare meeting on managing DKD.@pecoitsfilho – at Medchal, India
dkylies retweeted
Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy @jclinicalinvest by @Tobias_B_Huber and team jci.org/articles/view/147253
dkylies retweeted
Important new randomized trial in @JASN_News from @HeerspinkHiddo et al.
- SGLT2i + MRA lowers albuminuria more than either alone
- SGLT2i attenuates increases in K associated with MRAs
Demonstrating efficacy & safety advantages of combination treatment
jasn.asnjournals.org/content…
dkylies retweeted
Kidney survival is poor in patients with circulating anti–GBM antibodies & severe kidney injury. This study found that single dose of imlifidase led to kidney survival without major safety issues in 10 of 15 patients with anti-GBM disease & poor prognosis bit.ly/j2021111460
dkylies retweeted
Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series ajkd.org/article/S0272-6386(… @AJKDonline
dkylies retweeted
Data from the PEXIVAS trial challenged the role of PLEX in ANCA-associated vasculitides. This study found that PLEX was not linked with a better primary outcome in the whole study population, but identified a subset of patients who could benefit from PLEX bit.ly/j2021060771
dkylies retweeted
Findings of the PEXIVAS trial challenge the role of PLEX in ANCA-associated vasculitides. This study shows that a score incorporating kidney biopsy findings identifies patients with AAV who may benefit from PLEX, findings that need independent validation bit.ly/j2021060771




























